Terms: = Leukemia AND SPOP, TEF2, 8405, ENSG00000121067, O43791 AND Treatment
1 results:
1. Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens.
Wright S; Hu J; Wang H; Hyle J; Zhang Y; Du G; Konopleva MY; Kornblau SM; Djekidel MN; Rosikiewicz W; Xu B; Lu R; Yang JJ; Li C
Proc Natl Acad Sci U S A; 2023 Apr; 120(16):e2220134120. PubMed ID: 37036970
[TBL] [Abstract] [Full Text] [Related]
